- Home
- CBUS vs BRNS Comparison
CBUS vs BRNS Comparison
Compare CBUS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- BRNS
- Stock Information
- Founded
- CBUS 2010
- BRNS 2016
- Country
- CBUS United States
- BRNS United Kingdom
- Employees
- CBUS N/A
- BRNS N/A
- Industry
- CBUS Agricultural Chemicals
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- CBUS Industrials
- BRNS Health Care
- Exchange
- CBUS Nasdaq
- BRNS Nasdaq
- Market Cap
- CBUS 72.0M
- BRNS 64.6M
- IPO Year
- CBUS 2017
- BRNS 2021
- Fundamental
- Price
- CBUS $1.39
- BRNS $1.38
- Analyst Decision
- CBUS Strong Buy
- BRNS Strong Buy
- Analyst Count
- CBUS 2
- BRNS 1
- Target Price
- CBUS $21.25
- BRNS $3.00
- AVG Volume (30 Days)
- CBUS 185.7K
- BRNS 254.2K
- Earning Date
- CBUS 11-06-2025
- BRNS 11-05-2025
- Dividend Yield
- CBUS N/A
- BRNS N/A
- EPS Growth
- CBUS N/A
- BRNS N/A
- EPS
- CBUS N/A
- BRNS N/A
- Revenue
- CBUS $4,846,000.00
- BRNS $14,969,000.00
- Revenue This Year
- CBUS $17.67
- BRNS N/A
- Revenue Next Year
- CBUS $63.43
- BRNS N/A
- P/E Ratio
- CBUS N/A
- BRNS N/A
- Revenue Growth
- CBUS 63.66
- BRNS 1766.46
- 52 Week Low
- CBUS $1.20
- BRNS $0.64
- 52 Week High
- CBUS $6.10
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- CBUS 50.62
- BRNS 52.76
- Support Level
- CBUS $1.41
- BRNS $1.36
- Resistance Level
- CBUS $1.53
- BRNS $1.83
- Average True Range (ATR)
- CBUS 0.08
- BRNS 0.18
- MACD
- CBUS 0.02
- BRNS 0.02
- Stochastic Oscillator
- CBUS 51.79
- BRNS 43.04
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.